Steven D Roth

Title: Steven D Roth: Innovator in Delayed Release Pharmaceutical Compositions

Introduction

Steven D Roth is a notable inventor based in Great Neck, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of delayed release dosage forms. His innovative approach has the potential to enhance the efficacy of therapeutic drugs.

Latest Patents

Steven D Roth holds a patent for a delayed release pharmaceutical composition. This invention involves a solid dosage form that includes a core made up of a therapeutically effective amount of a drug, such as mesalamine. The composition features a pH-sensitive coating that consists of a mixture of two different pH-sensitive polymers. The first polymer dissolves in an aqueous solution at a pH of about 7 or greater, while the second polymer dissolves at a pH of about 6 or greater. The weight ratio of the first polymer to the second ranges from about 2:1 to about 4:1, and the weight gain from the pH-sensitive coating is between about 8% and 15% of the core.

Career Highlights

Steven D Roth is associated with Emet Pharmaceuticals, LLC, where he continues to work on innovative pharmaceutical solutions. His expertise in drug formulation and delivery systems has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Throughout his career, Steven has collaborated with talented professionals, including Madurai Gurusamy Ganesan and Ramaswamy Balakrishnan. These collaborations have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Steven D Roth is a distinguished inventor whose work in delayed release pharmaceutical compositions showcases his commitment to improving drug delivery systems. His innovative contributions continue to impact the pharmaceutical field positively.